Telomerase Inhibitors ‐ TMPyP4, BIBR 1532 and Imetelstat – Alter Adhesion Potential and Modify the Ability of Breast Cancer MCF7 and MDA‐MB‐231 Cells to form Spheroids
Błażej Rubiś(Poznan University of Medical Sciences), Kinga Rygiel(Poznan University of Medical Sciences)
Cited by 0
Related Papers
Vitamin C as a Modulator of the Response to Cancer Therapy
|Molecules|2019|104
Telomerase and drug resistance in cancer
|Cellular and Molecular Life Sciences|2017|102
The non-canonical functions of telomerase: to turn off or not to turn off
|Molecular Biology Reports|2018|61
Telomerase Inhibitor TMPyP4 Alters Adhesion and Migration of Breast-Cancer Cells MCF7 and MDA-MB-231
|International Journal of Molecular Sciences|2019|42
The Role of Telomerase in Breast Cancer’s Response to Therapy
|International Journal of Molecular Sciences|2022|39